ASX Earnings Calls
| Release date | Jan 27, 2026 |
| EPS estimate | $0.85 |
| EPS actual | $0.91 |
| EPS Surprise | 6.10% |
| Revenue estimate | 387.367M |
| Revenue actual | 402.218M |
| Revenue Surprise | 3.83% |
| Release date | Oct 28, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Aug 13, 2025 |
| EPS estimate | $0.88 |
| EPS actual | $0.87 |
| EPS Surprise | -1.14% |
| Revenue estimate | 374.229M |
| Revenue actual | 371.73M |
| Revenue Surprise | -0.668% |
| Release date | Aug 13, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for ASX
Below you can see how ASXFF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 13, 2025 |
| Price on release | $46.39 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 07, 2025 | $46.39 |
| Aug 08, 2025 | $45.10 |
| Aug 11, 2025 | $46.39 |
| Aug 12, 2025 | $45.10 |
| Aug 13, 2025 | $46.39 |
| Aug 14, 2025 | $46.39 |
| Aug 15, 2025 | $45.10 |
| Aug 18, 2025 | $46.39 |
| Aug 19, 2025 | $46.39 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Aug 13, 2025 |
| Price on release | $46.39 |
| EPS estimate | $0.88 |
| EPS actual | $0.87 |
| EPS surprise | -1.14% |
| Date | Price |
|---|---|
| Aug 07, 2025 | $46.39 |
| Aug 08, 2025 | $45.10 |
| Aug 11, 2025 | $46.39 |
| Aug 12, 2025 | $45.10 |
| Aug 13, 2025 | $46.39 |
| Aug 14, 2025 | $46.39 |
| Aug 15, 2025 | $45.10 |
| Aug 18, 2025 | $46.39 |
| Aug 19, 2025 | $46.39 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Oct 28, 2025 |
| Price on release | $37.75 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 22, 2025 | $38.31 |
| Oct 23, 2025 | $38.31 |
| Oct 24, 2025 | $39.50 |
| Oct 27, 2025 | $38.31 |
| Oct 28, 2025 | $37.75 |
| Oct 29, 2025 | $37.75 |
| Oct 30, 2025 | $37.75 |
| Oct 31, 2025 | $39.50 |
| Nov 03, 2025 | $35.00 |
| 4 days before | -1.46% |
| 4 days after | -7.28% |
| On release day | 0% |
| Change in period | -8.64% |
| Release date | Jan 27, 2026 |
| Price on release | $37.33 |
| EPS estimate | $0.85 |
| EPS actual | $0.91 |
| EPS surprise | 6.10% |
| Date | Price |
|---|---|
| Jan 21, 2026 | $34.72 |
| Jan 22, 2026 | $34.72 |
| Jan 23, 2026 | $34.72 |
| Jan 26, 2026 | $37.33 |
| Jan 27, 2026 | $37.33 |
| Jan 28, 2026 | $37.33 |
| Jan 29, 2026 | $37.33 |
| Jan 30, 2026 | $41.64 |
| Feb 02, 2026 | $41.64 |
| 4 days before | 7.52% |
| 4 days after | 11.55% |
| On release day | 0% |
| Change in period | 19.93% |
ASX Earnings Call Transcript Summary of Q4 2025
ASX reported a solid FY25 with operating revenue of $1.11bn (up 7%), underlying NPAT up 7.5% and statutory NPAT up 6%. EBITDA margin improved to 62.8% and underlying ROE rose to 13.6%. The Board declared a fully franked final dividend of $1.121 per share (85% of underlying NPAT), taking total FY25 dividends to $2.233 per share (up 7.4%). Business highlights: strong Markets, Technology & Data and Securities & Payments performance (notably futures/OTC and cash market trading growth), stable Listings revenue with improving momentum in H2 and healthy net new capital quoted. Technology modernization progress continues (Release 15 live; CHESS Release 1 targeted for Q4), but operational risk/resilience remains a priority and is being accelerated via the “Accelerate” program. ASIC has opened a compliance inquiry into ASX governance, capability and risk practices; ASX is cooperating and expects to incur incremental FY26 operating costs of $25–35m to respond (FY26 total expense growth guidance now 14–19%; excluding inquiry costs, core expense growth 8–11%). CapEx guidance is $170–180m for FY26 and $160–180m for FY27 with an intention to reduce CapEx after FY27. Net interest income rose (to $86.8m) driven by higher collateral balances and modestly higher spreads; collateral-related interest benefited from active portfolio positioning. Management reiterated medium-term targets: continued EBITDA margin expansion and an underlying ROE target range of 13%–14.5%. Key investor takeaways: strong underlying business cashflows and returns, clear technology and resilience investment program underway, near-term margin pressure from increased D&A and ASIC inquiry costs, continued focus on cost discipline and targeted product/data-led growth opportunities.
Sign In
Buy ASXFF